Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics

How to Design and Foster Thoracic Oncology Multidisciplinary Cancer Conferences<br>Guiding Principles in the Management of Synchronous and Metachronous Primary Non–Small Cell Lung Cancer<br>When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy<br>Management of Air Leaks and Residual Spaces Following Lung Resection<br>Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique<br>Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules<br>Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment<br>Constants and Currents in the Education and Training of General Thoracic Surgeons<br>Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy<br>Is Small Cell Lung Cancer a Surgical Disease at the Present Time?<br>Embolotherapy in Bronchial Hemorrhage<br>Ethics for Thoracic Surgeons in the Management of Lung Cancer<br>Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths<br>Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura<br>Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?